UNSPSC 51202600: Immunosupressant imides

This classification denotes organic substances consisting of two acyl groups bound to nitrogen, substances called imides, that reduce a human host's humoral and/or cell-mediated defense mechanisms against deviant native cells, foreign organisms, or foreign substances (the human immune response and system thereof), thus the term IMMUNOSUPRESSANT IMIDES.

UNSPSC 51202600 Immunosuppressant imides is a Class code that in practice covers a much broader range of pharmaceutical and medical products than its nominal name suggests—state and local governments are currently procuring naloxone, over-the-counter medications, generic pharmaceuticals, and emergency medical supplies under this classification. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire and rescue departments (City of Tampa), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and participating states). The code shows significant activity from health authorities and emergency response agencies seeking to source pharmaceuticals, medical consumables, and emergency supplies through formal competitive processes.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 2026, due July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 2026, due March 13, 2026) for 169 line items of medical and first aid supplies including respiratory equipment, cardiac electrodes, and consumables for the Fire Department Rescue Division, estimated at $700,000 with a certified Small Local Business Enterprise set-aside and 5 percent SLBE bid discount capped at $10,000; the Texas HHS Commission's RFI HHS0017013 (posted April 2026, due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription fulfillment programs; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with contract terms effective July 1, 2026. The code shows mismatch between its formal definition and actual procurement—state and local buyers are using it to classify emergency medical supplies, naloxone, and general pharmaceuticals rather than immunosuppressant imides specifically.